Skip to main content

A review of epigenetic changes in asthma: methylation and acetylation


Several studies show that childhood and adulthood asthma and its symptoms can be modulated through epigenetic modifications. Epigenetic changes are inheritable modifications that can modify the gene expression without changing the DNA sequence. The most common epigenetic alternations consist of DNA methylation and histone modifications. How these changes lead to asthmatic phenotype or promote the asthma features, in particular by immune pathways regulation, is an understudied topic. Since external effects, like exposure to tobacco smoke, air pollution, and drugs, influence both asthma development and the epigenome, elucidating the role of epigenetic changes in asthma is of great importance. This review presents available evidence on the epigenetic process that drives asthma genes and pathways, with a particular focus on DNA methylation, histone methylation, and acetylation. We gathered and assessed studies conducted in this field over the past two decades. Our study examined asthma in different aspects and also shed light on the limitations and the important factors involved in the outcomes of the studies. To date, most of the studies in this area have been carried out on DNA methylation. Therefore, the need for diagnostic and therapeutic applications through this molecular process calls for more research on the histone modifications in this disease.


Asthma is a heterogeneous inflammatory airway disease, affecting more than 300 million people globally in a different range of ages by a variable severity. The asthmatic phenotype can be provoked or enhanced by a broad range of triggers, including environmental risk factors, genetic factors, and epigenetic alternations [1,2,3]. The epigenetic alternation is defined as the chemical modifications applied to the genome deciding whether to express genes or how much of the genome should be expressed in different tissues of the body [4]. Epigenetic alternations, unlike genetic changes, can affect gene expression without changing the DNA sequence. Regular epigenetic modifications consist of DNA methylation, histone modifications, and changes in noncoding RNAs. DNA methylation can silence the genes by the addition of methyl groups to the C5 position of cytosine residues via DNA methyltransferases (Dnmts). This regulatory mechanism can also increase or decrease the expression of genes by hypomethylation and hypermethylation, respectively. Locations on the genome that are reported to have undergone methylation modifications are intergenic regions, gene body, and cytosine-phosphate-guanine (CpG) islands. Although most of the DNA methylation occurs in CpG islands, methylation within gene promoters is essential to the gene silencing process [5]. Gene regulation is also mediated by histone modifications that include histone acetylation, methylation, phosphorylation, and ubiquitination [6]. These post-translational changes can lead to chromatin remodeling and switch the structure between heterochromatin and euchromatin, turning the gene off and on. Two main enzymes in this process are histone acetyltransferases (HATs) and histone deacetylases (HDACs) that have an opposing effect on lysines. While HATs promote gene expression, HDACs have a gene suppressing function [7]. A simple summary of the process is depicted in Fig. 1.

Fig. 1

a When acetyl groups (COCH3) bind to histone tails via histone acetyltransferase (HAT), the DNA strand around nucleosomes loosens and, as a result, the gene will be expressed. Conversely, the removal of the acetyl groups by histone deacetylase (HDAC) turns off the gene transcription. b While the presence of methyl group (CH3) on cytosines inactivates the transcription of a gene, which is catalyzed by DNA methyltransferase (Dnmt), the DNA demethylation contributes to the gene expression

Aberrant epigenetic changes can result in a variety of disorders [8]. Respiratory diseases like asthma are highly affected by inflammatory gene expression which is correlated with epigenetic mechanisms. By the reversible nature of both methylation and acetylation, it is possible to develop drugs and diagnostic tools which target these mechanisms in genes engaged in inflammation as well as other characteristics of the disease [9, 10]. To that end, interrogating the influence of epigenetic changes on genes in different pathways involved in lung diseases such as neurotransmitter pathways can also be taken into consideration [11].

This review will examine the previous epigenetic-based studies on asthma written in the English language. First, we will discuss how asthma affects immune system genes and pathways by exerting methylation and acetylation elements. Then, we will indicate the divergent impact of these changes on distinct subjects. Afterward, the possible extrinsic influences on asthma predisposition through methylation and acetylation, including environmental exposure to tobacco smoke, air pollution, dust mite, and prenatal stress are assessed. Furthermore, during pregnancy, these factors not only affect the mother but also increase the risk of childhood asthma in the next generation [12]. Also, recent studies have shown the undeniable role of genetic and epigenetic interactions through cooperation between single-nucleotide polymorphisms (SNPs), which are DNA sequence variations of individuals, and CpG methylation in regulating gene expression and affecting asthma susceptibility [13]. Finally, conducted experiments on epigenetic differentiation determine how we can benefit more from these studies.

Airway inflammation in asthma

A variety of stimuli including air pollution particles, allergens, and viruses can trigger epithelial cells that act as a frontline barrier separating the external environment and the long. As a result of these triggers, airway epithelial cells and smooth muscle cells are activated following which they secrete a plethora of pro-inflammatory mediators such as cytokines (IL-5, IL-4, IL-13, and thymic stromal lymphopoietin (TSLP)), chemokines, and growth factors. In asthma, the interplay of activated dendritic cells (DCs), mast cells, and T helper cells type 2 (Th)2 lead to a perpetual type 2 response that mediates airway inflammatory responses [14]. On the other hand, Th1 cells produce different cytokines, including interferon-gamma (IFN-γ), which can suppress the development of Th2 cells [15]. Th1 and Th2 cells differentiate from naïve T-cells when encountering antigens and the absence of balance in their interaction leads to airway inflammation in asthma [16]. The production of IL-4 and IL-13 by Th2 cells leads to the interaction between T-cells and B-cells, thereby inducing B-cells to produce IgE [17]. Besides, the release of IL-25 and IL-33 from activated epithelial cells together with prostaglandin D2 derived from mast cells activates ILC2. ILC2 is of a pivotal role in promoting type 2 responses in asthma through the production of IL-13 and IL-5, with the former involved in bronchial hyperreactivity and the latter in airway eosinophilia [17, 18]. Asthma exacerbation is governed by the recruitment of neutrophils that is predominantly promoted by Th17 cells and the production of IL-17 [19]. Ultimately, all of these processes contribute to the bronchial hyperreactivity and asthmatic and allergic phenotypes (Fig. 2).

Fig. 2

Allergens stimulate structural cells (epithelial cells and smooth muscle cells) to produce different kinds of cytokines, including IL-5, IL-4, IL-13, and thymic stromal lymphopoietin (TSLP). This process activates naïve T-cells (Th0) to differentiate into Th1 and Th2 cells. The imbalance between these T-cells would lead to inflammation in asthma. Released cytokines from Th2 result in IgE production from B-cells, which bind to their receptors on mast cells. Mast cell-derived prostaglandin D2 (PGD2) and Th2 cytokines activate ILC2, which can provoke eosinophilia and hyperactivity in asthma. Th17 and IL-17 are involved in asthma exacerbation by recruitment of neutrophils

Asthma-related genes and pathways

Cohorts of asthma patients are diagnosed with high levels of nitric oxide (NO) in their airways [20]. This endogenous product of mammalians has a key role in asthma pathogenesis, which is reviewed in detail by Ghosh and Erzurum [21]. Increased level of NO is the consequence of induced nitric oxide synthase (iNOS) upregulation at the transcriptional stage, in the bronchial epithelium. Increased level of iNOS expression accompanied by eosinophil augmentation in allergic response is associated with the fractional concentration of NO (FeNO) [22]. In the nitric oxide pathway, FeNO is regulated by the expression of different isoforms of arginase (ARG) and NOS. The promoter methylation of ARG1 and ARG2 in buccal cells of asthmatic children was associated with the restrained level of FeNO, whereas there was no link between methylation of NOS and the level of FeNO [23]. Nevertheless, Baccarelli et al. [24] reported that high levels of FeNO in asthmatic children were inversely correlated with DNA methylation of iNOS and IL-6 in nasal cells. Although this study could not investigate the effect of methylation on the transcriptional level of these genes, several studies suggest that the methylation change in iNOS and IL-6 promoter leads to their mRNA level regulation [25,26,27], which can, in turn, affect the airway inflammation in asthmatics. In addition to DNA methylation, dimethylation, and trimethylation of histone H3 lysine 9 in iNOS promoter can be involved in its response; this was observed in primary human vascular endothelial cells [25]. Therefore, being able to affect the extent of NO production and the subsequent inflammation in asthmatics, DNA methylation and histone modification at NO pathway genes are a worthwhile target for treatment strategies.

The T helper cells, comprising Th1 and Th2, and their cytokines are differentiated, polarized, and their function is predominantly regulated by the epigenome [28]. In asthma, Th2 cytokines IL-4, IL-13, and IL-5 play a major role in stimulating airway inflammation [29], whereas Th1 cells suppress airway hyperreactivity by producing IFN-γ [30, 31]. Downregulated expression of IFN-γ in CD4 + T-cells is found associated with its increased DNA methylation in response to allergic asthma in female mice [32]. On the contrary, a study in 2008 [33] reported a decrease in the methylation degree of the IFN-γ and IL-4 genes and a following increased expression, in CD4 + T-cells isolated from asthmatic patients, after stimulation with different strains of a house dust mite. In the in vivo experiment ran by Verma et al. [34] the expression of IFN-γ and IL-6, analyzed in mRNA profiling, was significantly low in asthmatic Balb/c mice bronchoalveolar lavage fluid (BALF) cells, trachea, and lung tissues. This low degree was the result of DNMT1 promoter methylation, a gene on which regulation and development of Th1 and Th2 cells are dependent [34]. Additionally, an increased level of IL-4 and IL-13 in asthmatic primary human bronchial epithelial cells was observed to disrupt the barrier integrity of these cells, which is a defense mechanism in airways. The upregulation of these Th2 cytokines was followed by HDACs 1 and 9 upregulation which was correlated with the defective epithelial barrier [35]. A recent genome-wide study of DNA methylation in nasal epithelium of children with atopy and atopic asthma also has reported several genes associated with Th signaling and epithelium integrity, providing supporting evidence for utilizing methylation status as an asthma diagnostic tool [36]. Therefore, methylation and acetylation on the genes associated with Th cells and the cytokines engaged in inflammation and barrier integrity play a key role in regulating their expression and function in this disease.

Li et al. [37] demonstrate that in peripheral blood of asthmatics, Th2 polarization is inversely correlated with the rate of the linker for activation of T-cells (LAT), Th2 cytokines were significantly upregulated, and LAT expression was decreased. This decrement was attributed to hypoacetylation of LAT that was observed in lung T-cells of asthmatic rat models. It is notable that trichostatin A treatment in vitro was able to reverse the acetylation level and retrieve LAT mRNA expression and thus restrain Th2 cytokine production [37]. The Th1 and Th2 differentiation is also regulated by the enhancers that are specifically methylated in primary T-cells isolated from peripheral blood, varying in healthy subjects and asthmatics. Disease-specific enhancers are prone to acquire dimethylation at histone H3 Lys4 during Th2 differentiation; this is suggested to be involved in asthma pathogenesis [38]. Besides, the suppressor of cytokine signaling-3 (Socs3) regulates the interrelation between Th1 and Th2 cells in asthma [39]. The detected Socs3 overexpression in asthmatic mice lung tissue is owing to the high levels of histone H4 acetylation at its promoter [40]. This higher level of acetylation, which may lead to tissue remodeling and asthma pathogenesis, was modulated by IL-6. In another study, a high methylation level in the CpG region of the IL-1 receptor 2 (IL1R) 2 gene, which is associated with atopic and non-atopic asthma, was found to be the reason for IL1R2 low mRNA level in asthmatic individuals' blood [41]. Moreover, in primary bronchial epithelial cell lines derived from asthmatic patients and non-asthmatics, differentiated DNA methylation of IL-33, a family member of IL-1, and CCL26, an IL-33 downstream gene, was concordant with asthma status, with the latter showing lower methylation level in response to severe asthma. Nevertheless, despite the positive association found between eosinophil cell count and CCL26 expression, elevated mRNA level of CCL26 and IL-33 in asthmatics was not discriminative between the subjects and controls [42].

In addition to cytokines, the expression of specific chemokines, known as the CXC family, that are responsible for inflammatory cell migration in epithelial cells [43] can also be driven by epigenetic mechanisms. Asthmatics with increased CXCL8, which is a CXC chemokine, secretion in airway smooth muscle cells are prone to promoting steroid-resistant airway inflammation [44, 45]. This upregulation was perceived to be concordant with increased histone H3Lys18 acetylation and an increased number of p300 HATs but not with DNA methylation in primary cultures of human ASM cells isolated from individuals with and without asthma. Moreover, Clifford et al. [44] proposed utilizing BET protein inhibitors as an approach to modify CXCL8 promoter bindings and thus preventing CXCL8 secretion.

In another study, the HAT loss resulted in the downregulation of the ORMDL3 gene, which is a childhood asthma gene. Higher levels of accumulated P300 HATs at ORMDL3 promoter and, therefore, increased acetylation of this gene in lung tissue of asthmatic mice distinguished them from controls [46]. In steroid-resistant asthmatics, defective response to glucocorticoids in bronchial lavage cells stemmed from the GRβ overexpression effect on GRβ factors located on the HDAC2 promoter [47]. To that end, Li and colleagues [47] indicated that by in vitro silencing glucocorticoid receptor β (GRβ), the decreased expression level of HDAC2 in bronchial lavage cells could be reverted and increased; besides, this result could not similarly be obtained from peripheral blood mononuclear cells (PBMC). On the contrary, Butler et al. [48] claimed that the level of GRβ was low in people with severe asthma and there was no downregulation affected by GRβ in the level of HDAC1 or HDAC2 in primary bronchial epithelial cells. Notably, the study by Gunawardhana et al. [49] proposed a crosstalk correlation between HDAC and HAT enzyme activities in peripheral blood monocytes of adult neutrophilic asthmatics as increased HAT activity was accompanied by HDAC activity decrement. However, these alternations in the state of activity were not originated from the expression of HDAC1, HDAC2, and other assessed genes. This discordance may be due to the studied tissue type, concerning the fact that epigenetic alternations are tissue-specific [50]. Nevertheless, in an in vivo experiment, Stadhouders et al. [51] have recently demonstrated that subjects with airway inflammation had a similar pattern of histone H3 lys4 dimethylation in group 2 innate lymphoid cells (ILC2s) in different tissues, yet the expression was tissue-specific.

In summary, the interplay between Th1 and Th2, as the promoting factor of inflammation, is driven and disrupted in asthma by epigenetic modifications. Decreased methylation and increased acetylation in Th2 genes lead to an aggravated inflammatory response in asthma. Nevertheless, methylation or acetylation variations in asthma cannot always determine the change in gene expression. Tissue and cell-specific epigenetic interrogations gain better results as epigenetic changes differ in different tissues and also in different cells from the same tissue. Most studies were carried out in vitro, and the most studied tissue was peripheral blood as it was the simplest one to obtain from subjects. Importantly, some studies indicated that the altered methylation and changed expression of some asthma-related genes were not correlated to asthma; therefore, it makes it harder to rely on the results from epigenetic studies that did not measure mRNA expression. Replication of the experiments in another tissue is quite beneficial since it can elucidate the most viable cell or tissue for observing epigenetic regulations in specific genes. Tables 1 and 2 present a brief view of the findings on asthma-related genes and pathways which are reviewed in this chapter.

Table 1 Summary of the research works about the DNA methylation role in asthma-related genes and pathways
Table 2 Summary of the research works about the role of histone acetylation and its regulatory enzymes in asthma-related genes and pathways

The impact of subject's characteristics

The degree of DNA methylation and asthma susceptibility may vary based on gender type, age of the subject, and certain disorders along with asthma. To that end, Naumova et al. [52] proposed the ZPBP2 gene in the 17q12-q21 region within which DNA methylation varied not only between male and female asthmatics but also between different ranges of ages. Significance in the differentiation of PBMC DNA methylation status was only observed in male subjects, and the methylation level in adults was higher than in boys. Likewise, in the findings of Reinius et al. [53], adult subjects showed a higher methylation ratio in peripheral blood in comparison with children. Furthermore, interrogating genotype-dependent differentially methylated regions in 5q31 and 17q21 regions led to finding three genes, GSDMA, ZPBP2, and SLC22A5 whose promoter methylation was dependent on genotype, sex, and asthma status. Males and females showed a different association between peripheral blood DNA methylation and asthma for each gene [54]. The association between asthma symptoms and the blood spot-derived DNA methylation of AXL, a childhood asthma-related gene, was more apparent in girls rather than boys at the same age [55]. On the contrary, Lovinsky-Desir et al. [56] inferred that the methylation level of the IFN-γ promoter in PBMC CD4 + lymphocytes and buccal samples was higher in children than adults, and higher in males than females but not in a buccal cell, and with the increase of males' age, the methylation degree decreased. Comparing different tissue types added so much value to their findings as it shed light on the fact that the type of cells can hamper the results derived from an epigenetic study.

The DNA methylation alternations throughout the life span are employed as a biological clock. This DNA methylation clock, which is also a biomarker for different diseases including lung cancer [57], may be able to explain age association in allergic diseases [58]. To find the correlation of age with methylation changes and occurrence of asthma, several studies have been done on birth cohort populations following up the subjects before and after birth and investigating their status at certain ages. Employing the Hovath method [59], DNA methylation age was evaluated in three stages of childhood and was considered older than chronological age. In middle childhood (7 to 8 years of age), epigenetic age acceleration was concordant with increased IgE in serum and, accordingly, associated with the risk of allergy and asthma, increasing the odds of these diseases as the methylation age increased [60]. Furthermore, Curtin et al. [61] demonstrated the positive correlation between the increased age of participant children (between ages 2–8), augmented methylation of IL-2 in cord blood, and the risk of asthma exacerbation. Notably, these children were prenatally classified as high and low risk for asthma regarding their parents' atopy status; however, maternal atopy was reported unrelated to IL-2 methylation at one site and, additionally, atopic children with atopic mothers were of lower methylation in another site of IL-2 compared with children with non-atopic mothers. Differentiated methylation on Th2 pathway genes, IL4, IL4R, and GATA3, in peripheral blood, was distinguishable between female subjects who had asthma at 10 but grew out of it at 18 and the ones healthy at 10 but showed asthma symptoms at 18 [62]. Furthermore, exposure to vaccines and pills in females may affect the epigenetic regulations and thus asthma susceptibility. Another study on a whole population birth cohort reported differentiated DNA methylation patterns in certain CpG sites in the Guthrie cards and whole blood of followed-up female participants who had Tetanus vaccination between the ages 10 and 18. At age 18, this observed altered CpG methylation level was associated with lower odds of asthma susceptibility, so it can be proposed as a preventative approach against developing this disease [63]. In contrast, consuming oral contraceptive pills (OCP) at age 18 was reported to increase the predisposition to asthma by impacting the GATA3 gene through the SNP-CpG methylation interplay, which was assessed using peripheral blood cells and saliva samples (Fig. 3) [64]. In another study, by investigating the DNA extracted from older smokers 'sputum, Sood et al. [65] found the association of asthma and the methylation of the protocadherin-20 gene whose methylation degree was emerged to be higher than the healthy group with a similar smoking history. Although this study does not directly address the effect of age on DNA methylation in asthmatic subjects, it provides evidence that as people age the influence of the environment (smoking) increases and may affect the susceptibility to the disease. Yet, this still cannot prove whether asthma was the consequence of an accumulation of methylation during lifetime or asthma inflammation itself led to further methylation of specific genes in these individuals.

Fig. 3

Oral contraceptive pills (OCP), which are used in different conditions, at the age of menarche, can affect GATA3 methylation level in cytosine-phosphate-guanine (CpG) sites via, presumably, sex hormones. Interaction between GATA3 single-nucleotide polymorphisms (SNPs) and OCP is influenced by these methylation changes, which affect the immunological process leading to asthma

In addition to sex and age, there are disorders, like obesity, that can relate epigenetic of asthma to the subject's characteristics. Obesity and high body mass index (BMI) are believed to impact non-atopic asthma [66, 67]. Rastogi and colleagues [68] reported that in PBMCs of obese asthmatic children, genes associated with Th1 polarization and macrophage activation pathway were hypomethylated, whereas genes related to T-cell-mediated inflammation were hypermethylated. These results are consistent with the findings of Jeong et al. [69] that indicated that DNA methylation derived from peripheral blood may be a key link to associate adult non-atopic asthma with BMI status and its change over a while. DNA methylation differentiation in pro-inflammatory pathway genes was considered to mediate the correlation of inflammatory signaling pathways with BMI and NLRP3-IL1B-IL17 axis with BMI shift in 10 years. Another disorder that may influence asthma is Alzheimer's disease. Wu et al. [70], by conducting an in vivo experiment have recently demonstrated that ovalbumin-induced mice with Alzheimer's disease are seen with more regulatory T-cells (Tregs) and forkhead box P3 (Foxp3) expression in their lungs, and therefore showing mitigated asthma symptoms compared to the controls. They have suggested that Foxp3 upregulation may be due to the drop observed in the promoter methylation level of this gene in isolated BALF cells.

These studies highlight the importance of considering gender- and age-specific epigenetic patterns along with the influence of drugs, vaccines, and disorders in asthma. In this section, most of the studies have considered the age factor by using birth cohort samples in their experiments. Despite the limitations in this process, such as only being able to measure the methylation changes at certain time points, these studies have achieved more valuable results as methylation profiles transform throughout a lifetime. Although most of the studies are carried out on children implying the importance of early-life epigenetic modification, the age in which these methylation changes have their highest impact on an individual's asthmatic status is not established yet. According to Hovath and Steve [59], there is a logarithmic association between chronological age and methylation age by 20 years of age but a linear relation after that. Although different aspects should be considered in studying the effects of aging on the methylation status and finally the odds of asthma, aging can be simply seen as more time for the accumulation of asthma risk factors. Of note, the most important thing that was missing in these studies was that not all of them measured the transcriptional level after detecting the methylation changes in asthma-related genes. Peripheral blood was used in almost all of the studies in this section, and the studies which compared peripheral blood and whole blood inferred that whole blood could not fully reflect methylation changes in subjects. Table 3 demonstrates a summary of the articles on the role of characteristics of the subjects who developed asthma on their methylation status.

Table 3 Summary of the studies on the impact of the subject's characteristics on the methylation status in asthma

Environmental exposure

Early-life exposure to asthma risk factors affects childhood and adulthood health and the susceptibility to chronic diseases like asthma [71]. Throughout the number of studies on asthma, environmental factors have proved their influence on the epigenome and gene expression. Therefore, it is of great importance to interrogate how the external factors provoke molecular changes and evaluate the inheritance possibility of the resulting changes.

Asthma predisposition caused by exposure to cigarette smoke

Asthmatic mothers with different severity of active asthma were able to pass the disease to their offspring, and this may be carried out by epigenetic regulations, regarding their affectability from the environment [72]. In utero exposure to cigarette smoke or secondhand smoke is one of the reasons for lung malfunction and the increase of the asthmatic phenotypes in populations [73, 74]. In an in vivo experiment, sensitized mice with tobacco smoke in utero were exposed to dust mite to develop allergic asthma. Induced allergic asthma led to lower levels of methylation in inflammatory-related genes, comprising IL-4, IL-5, IL-13, and also global DNA methylation in their lung tissue; therefore, more Th2 cytokines were produced resulting in lung inflammation [75]. Since mRNA level was not evaluated in their study and the measurements were not cell-specific but only tissue-specific, increased protein level cannot be attributed merely to DNA methylation changes. Investigating the epigenetic effect of prenatal tobacco smoking on developing childhood asthma, Gao et al. [76] found the extent of AXL methylation at birth, measured in bloodspots, associated with maternal smoking and rising asthma symptoms such as wheezing at age 10 in two population study cohorts.

Additionally, Neophytou et al. [77] indicated that the reported exposure to prenatal maternal tobacco smoke in 8- to 21-year-old asthmatic Latino children was associated with higher methylation levels in the AHHR gene measured in whole blood. While most studies support the role of maternal smoking in developing asthma in offsprings [74], paternal tobacco smoking can also reprogram the offspring's epigenome. Analysis of cord blood and blood samples were taken right after birth and then at the age of 18 months and 6 years, respectively, showed the role of paternal smoking in higher CpG methylation of LMO2 and IL-10 immune genes, and that the extent of methylation was associated with the dose of smoking [78]. Furthermore, Sarnowski et al. [79] indicated that a paternally inherited genetic variant, related to asthma and allergic rhinitis comorbidity, was regulated by differentiated DNA methylation patterns of MTNR1A in peripheral blood leukocytes. DNA methylation of this gene also mediated the SNP related to asthma and allergic rhinitis comorbidity. Given these points, both parents can be involved in developing asthma in their children through epigenetic alternations driven by exposure to cigarette smoke prenatally and postnatally.

Exposure to air pollutants and chemical substances

Air pollution-related exposure, in different stages of life, can determine the susceptibility to asthma by epigenetic modulations. Transplacental exposure to traffic-related polycyclic aromatic hydrocarbons was reported to alter the methylation of the ACSL3 CpG site in umbilical cord white blood cells. This modification was concordant with ACSL3 expression obtained from matching fetal placental tissue, and thus downregulated the transcription and increased childhood asthma predisposition in children under five [80]. By studying the short-term exposure to PM2.5 and vanadium, Jung et al. [81] inferred that only vanadium, not PM2.5, altered the DNA methylation of IL4 and IFN- γ in buccal samples, but this alternation was not concordant with defected lung function. On the contrary, PM2.5 exposures were correlated with the lung function decrement. Differentiation of FOXP3 and IL10 DNA methylation was identified in the PBMC of children with asthma who were exposed to NO2, CO, and PM2.5 in the long term (2 years), and the methylation of FOXP3 promoter augmented because of all three types of pollutants mentioned. Although occurred methylation did not affect the FOXP3 expression, it was negatively correlated with the activation of Treg cells [82]. Besides, exposing mice to the concurring effect of PM2.5 and cold stress resulted in the decrement of HDAC1 and hyperacetylation of H3K9 and H3K14 in IL4 promoter in CD4 + cells isolated from BALF. This study also indicates that the exacerbation of asthma is more likely to occur when exposed to various asthma risk factors rather than one [83].

Another set of air pollutants that affect asthma pathway genes epigenetically is black carbon and sulfate. Exposure to these particular pollutants was associated with differentiated DNA methylation of genes related to major histocompatibility complex, eotaxins, ILs, cytokines, eosinophil granule major basic protein, and IgE receptors in peripheral blood. One of the influenced genes for the latter was FCER1G, the only one that was affected by both black carbon and sulfate [84]. Exposure to higher levels of black carbon is correlated to lower levels of IL-4 methylation in children's buccal cells; this methylation level was even lower in children sensitized with cockroach allergens than in non-sensitized children [85]. In vitro analysis of nasal epithelial cells derived from siblings between 5 and 18 years old identified three CpG sites related to childhood asthma none of which witnessed statistically significant methylation change when the cells were exposed to air pollution in asthmatics. Nonetheless, these CpG sites were close to NLRP3, OR2B11, and TET-1 genes whose expression was altered in cultured cells as a response to house dust mite and diesel exhaust particles [86]. In line with the previous study, Somineni et al. [87] reported that in nasal airway epithelial cells, higher and lower methylation of a certain CpG site of TET-1 was associated with exposure to traffic-related air pollutants and asthma in children, respectively.

In addition to air pollutants, there are several toxic environmental substances used in various products that their connection with asthma and methylation marks is investigated. Kuo et al. [88] reported that phthalate is associated with an increased risk of asthma because of promoting Th2 response and compromising IFN alpha/IFN beta expression in plasmacytoid dendritic cells isolated from peripheral blood. Phthalate exposure could also attenuate the methylation level of TNF-α in whole blood white blood cells and lead to its upregulation, which is an event that increases the risk of asthma in children [89]. The results from another study indicate that exposure to bisphenol A can lead to a decrease in an inflammatory mediator gene MAPK1 methylation in whole blood, provoking childhood asthma [90]. Studies on inner-city children with persistent atopic asthma suggested that persistence in these children was accompanied by promoting the expression of genes related to Th2 immunity. This upregulation was the consequence of IL-4, IL-13, and RUNX3 hypomethylation measured in PBMCs of asthmatic patients compared to the control group [91]. In another study on inner-city children, the results elicited from saliva or whole blood DNA of asthmatics exhibited that increased methylation in the beta-2 adrenergic receptor gene (ADRB2) was correlated to decreased dyspnea and asthma severity [92]. Conversely, Fu et al. [93] found that higher levels of the ADRB2 methylation in blood increase childhood asthma severity. The hypermethylation in ADRB2 was also suggested to augment the influence of NO2 exposure in asthmatic children and exacerbate the level of asthma [93]. Besides, in a recent study, a positive association between the hypermethylation of this gene and uncontrolled childhood bronchial asthma has been shown. Also, there is a positive correlation between the augmented methylation of ADRB2 and increased aluminum concentration measured in whole blood [94]. These findings support this hypothesis that there is a synergic relation between environmental asthma risk factors and epigenetic changes.

Other external influences

Considering race, ethnicity, socioeconomic status, and asthma severity in asthmatic children with low salary families, Chan et al. [95] indicated that higher global methylation of peripheral blood cells was related to African-Americans with persistent asthma whose families had low incomes. Moreover, assessing asthma and/or rhinitis-related CpG regions in African-American and Puerto Rican children led to identifying one site cg03565274 that was significantly methylated and altered the expression of the ZMYND10 gene in nasal epithelial cells. This region and the majority of other 60 identified CpG sites were correlated with the exposure of children to fury pets at secondary school age [96]. In utero malnutrition has been found as another external factor of increasing experimental asthma risk in offsprings both in vivo and in vitro. Bisulfate sequencing of extracted DNA from naive CD4 + cells isolated from spleens demonstrated increased hypomethylation in Th2 cytokines due to in utero protein restriction diet. As a result, CD4 + T-cell proliferation, activation, and their tendency to differentiate into Th2 cells elevated [97]. Taking selenium and methyl donor nutrients in children with asthma may contribute to alleviating asthma, but it was not clear whether DNA methylation in buccal cells or other epigenetic regulations mediated this process [98]. Furthermore, even seasonal change, as an environmental factor, had an impact on the methylation pattern of NSPR1 promoter in whole blood, an asthma-related gene during the disease period [53]. According to Torrone et al. [99], the duration of asthma and the short-term environmental change affected iNOS and IFN-γ methylation degree in buccal cells in a 4- to 7-day period of the disease. This demonstrates the dynamic feasibility of the epigenome related to the asthma genes in response to environmental transformations. In a recent in vitro study, early viral infection with human rhinovirus was also observed to be effective on DNA methylation and then mRNA expression differentiation in asthmatic children's cultured primary nasal epithelial cells [100].

Probable transgenerational immunity against asthma

Microbial exposure as a preventative approach in allergic diseases is an understudied topic. According to the hygiene hypothesis, being exposed to microbial environments in early life can affect host immunity and reduce the risk of allergic diseases, including asthma [101]. Different factors that are involved in shaping a protective immunity against allergic diseases include delivery mode (cesarean or vaginal), breastfeeding, contacting with a wider range of people, growing up in a rural environment, and probiotics [102]. Although these factors are highly supported by different studies, there are still limitations to assess this matter fully due to the existing biases and contradictory studies. For instance, probiotic bacteria influence the microbiome development in early life and have shown positive effects on atopic dermatitis prevention [103]; however, some studies indicate their opposite effects for asthma [104, 105]. Just like in utero and early exposures to asthma risk factors in early life that may elevate the odds of asthma in childhood and adulthood, being exposed to harmless infections at the same period may have a positive impact against asthma. As the hygiene hypothesis indicated first-year exposure to the farm environment, as opposed to later exposure, was remarkably associated with asthma [101]. In addition to that, the duration of this exposure was taken into account, meaning that children who spent more time on farms (children of full-time farmers) were less susceptible to asthma [106]. Since epigenetic modifications are highly affected by the environment, evaluating the effects of this kind of exposure on the epigenetic process is a viable solution to clarify this phenomenon and contribute to its understanding.

Brand et al. [107] assessed the epigenetic alternation in murine offspring in which prenatal asthma protection was induced by Acinetobacter lwoffii F78, a farm-derived gram-negative bacterium. Their results demonstrated that transitional protection altered H4 acetylation and led to forming an asthma preventative phenotype. Michel et al. [108] called into question the effect of farm exposure on the DNA methylation pattern and asthma development in children whom they followed until 4.5 years of age. Their basis of comparisons regarding DNA methylation status was fourfold: asthmatics, non-asthmatics, farmers' children, and non-farmers' children. Within examined ten genes in cord blood, the methylation status of ORMDL1 and STAT6 in healthy farmers 'children in comparison with nonfarmers' children with asthma was distinguishable. On the other hand, carrying out the same comparisons for methylation degrees in whole blood samples of these children at 4.5 years of age did not bring out considerable methylation changes between compared groups. In a recent study on the diversity of the gut microbiome, Kyburz et al. [109] exposed female mice to helicobacter pylori extract and examined their offsprings for the next two generations. Both F1 and F2 generations have been subjected to house dust mite allergen. As a result of sensitization to the bacterium, in both generations, the susceptibility to airway inflammation was reduced. This reduction was evaluated by observing a drop by 5 to 15 percent in Foxp3 methylation status after treatment with pylori extract. Studying allergen-specific immunotherapy, Wang et al. [110] investigated the molecular mechanism of this effective therapy in PBMC of asthmatic children who were treated with Dermatophagoides pteronyssinus and also in vitro stimulation in cultured PBMCs. Accordingly, increased DNA methylation of IL-4 promoter and lower release of IL-4, IL-5, and IL-2 were observed, which was put down to decreased sensitization to that specific dust mite. Epigenetic studies may help to identify specific time points when microbiome exposure is of the highest impact as age has a significant effect on epigenetic regulations. However, long-term maintenance of this protection and its effectiveness is yet to be discovered.

To conclude, only a few studies have been conducted on adults and the largest proportion was dedicated to children which included several follow-up studies. The studies on the role of epigenetic modulations in developing asthma protection are very limited and there is still considerable ambiguity in this area that demands to be unraveled in further studies. The most used tissue type was PBMC which can be considered a negative point, although it has a higher value compared with the heterogeneity of cell types in whole blood [111]. Also, common limitations in these studies were lacking ample study cohort size and not being able to carry out replications to evaluate their results. Moreover, although the role of maternal status in the development of asthma is undeniable, there is not enough evidence on the epigenetic mechanisms underlying these effects on offsprings. Both Th1- and Th2-related genes undergo epigenetic modifications that resulted from environmental effects. Exposure to different types of air pollutants or environmental chemicals affects both DNA methylation and histone modifications. Table 4 indicates the reviewed articles in the field of transgenerational effects and environmental exposure.

Table 4 Summary of studies on transgenerational effects of epigenetic regulations in asthma

Asthma development later in life and the next generations

In the previous section, we discussed how external factors could cause epigenetic changes and thus provoke asthma in individuals. These changes that seem to stem from prenatal and postnatal exposures are heritable, and they can dispose to different diseases such as asthma [112]. These epigenetic alternations in early life can provide useful information about the propensity for childhood and adulthood asthma. Besides, studies have shown that these changes may also persist into subsequent generations, also disposing them of the disease [112].

Reflection of propensity to asthma in the epigenetic pattern

Studies have shown that it could be possible to detect the tendency to childhood or adulthood asthma in early life via the epigenetic pattern associated with immune and pro-inflammatory pathways. Augmented methylation of SMAD3 in cord blood mononuclear cells of newborns, which was associated with the inflammatory regulator IL-1b, determined whether or not the subjects, all with asthmatic mothers, would develop asthma by age 9 [113]. These epigenetic changes can be better observed in monozygotic twin studies as they maintain the same genome but acquire a diverse epigenome. As twins grow older, they become easier to be discriminated by their epigenome from which their phenotypic differences can result. In monozygotic twins who were discordant in childhood asthma at age 10, the upstream region of HGSNAT gene was differentially methylated in buccal cells, whereas after eight years follow-up methylation pattern of HLX gene was associated with maintained asthma discordance at age 18 [114]. These findings suggest that while some gene methylation patterns are mitigated through time, some persist into adulthood. Yue et al. [115] showed that exposing pregnant mice to NO2 stimulated inflammatory responses through demethylation of the IL-4 gene and Th2 differentiation in offsprings, which yielded adulthood allergic asthma. Likewise, a recent meta-analysis study has shown that methylation alternations of genes related to lung function that was detectible at birth in cord blood samples can bring about asthma development or other obstructive diseases in adulthood [116]. In an epigenome-wide association study, adolescent asthma was also shown to be predictable by early-life evaluation of the methylation at one CpG site within the HK1 gene and its expression in cord blood [117]. Therefore, early-life epigenetic patterns could be a sign of asthma risk later in life span, and cord blood appears to be an ideal tissue type for detection of methylation signatures at birth.

Transgenerational effects

Prenatal exposure has also revealed its influence on later generations by increasing asthma susceptibility that can be facilitated through aberrant epigenetic modifications. Rehan et al. [118] reported that single perinatal nicotine exposure in pups was able to alter DNA methylation and histone H3 acetylation in germ and somatic cells of the F1 generation male offsprings. Additionally, the subsequent F2 generation of these pups showed increased asthma susceptibility. Further, the risk of asthma was followed in the third generation of the pregnant mice exposed to diesel exhaust particles, and the result was the persistence of the methylation marks in that generation [119]. Despite the variable susceptibility to asthma in the three subsequent generations, they had differentiated DC-derived DNA methylation in the same loci; the loci were associated with chromatin remodeling [119]. Hypermethylation and hypomethylation in different loci of dendritic cells revealed their involvement in the transmission of maternal asthma, but part of these modifications did not cooperate in provoking the asthmatic or allergic phenotype [120, 121]. Infants born to asthmatic mothers emerged to have differentiated methylation in various loci of the DNA extracted from their peripheral blood, which may predispose them to asthma later in life [122]. In other words, offsprings' methylation pattern can be influenced by their mother's phenotype during pregnancy; as a result, this may predispose their children to a higher risk of asthma. Nevertheless, not all of these methylation changes transmitted from asthmatic mothers can lead to the disease phenotype.

In essence, the methylation patterns after birth may mirror the changes in the shared environment between the infant and the mother during pregnancy. Also, methylation changes in the early stages of life after birth may provoke asthma in childhood and adulthood, and there is a probability of persistence of these modified methylation patterns into the next generations. However, there were only limited in vivo experiments on the inheritance of methylation markers to the next generations, and no human research has been carried out. The overall environmental effects on pregnant mothers and their offsprings are illustrated in Fig. 4. Table 5 presents a summary of the studies in this section.

Fig. 4

Pre- and postnatal exposure to epigenetic-mediated asthma stimulators and their outcomes. a Asthma triggers comprising tobacco smoking, house dust mite, air pollution, and lifestyle can negatively regulate the fetus epigenome. b Monozygotic twins that were exposed to these triggers in utero may or may not develop childhood asthma. c The microbiome may develop a protective epigenome in the offspring against asthma. d External factors can affect the person after birth. e The epigenetic changes seen in early life may affect the phenotype in childhood or adulthood, and those who showed the symptoms in childhood may recover in adulthood while those who were healthy children may become adults with asthmatic symptoms

Table 5 Summary of the research works about the role of epigenetics in determining the propensity for asthma later in life and in the next generations

SNPs and methylation interaction

Single-nucleotide polymorphisms (SNPs) can be influenced by environmental exposure, which may provoke different human diseases [123], including asthma. Therefore, several studies have presented the interplay of SNPs and DNA methylation on the pathogenesis of asthma. Mediation analysis of asthma-related SNPs identified through genome-wide analysis studies (GWAS) demonstrated that DNA methylation mediation accounted for about 47 percent of differentiated expression of SNP-associated distant cis-genes in nasal epithelial cells, which were correlated to childhood atopic asthma [124]. A considerable number of asthma-related SNPs were located on Th2 cells enhancers, a region in which the highest rate of H3K4 dimethylation was measured in primary human CD4 + T-cells [38]. Of note, the higher the degree of H3K4 methylation, the higher the odds of H3 acetylation and inhibition of DNA methylation whereby the activation of gene transcription is ensured [125, 126]. Besides, Zhang et al. [62] demonstrated that the interactions between SNPs and DNA methylation of CpG regions in Th2 pathway genes (IL-4, IL-4R, IL13, STAT6, and GATA3) in peripheral blood leucocytes were concordant with asthma risk but the results varied in different time points. In another research on a whole-population birth cohort, only one SNP was found correlated to one CpG region of the IL-4 receptor gene (IL-4R) whose methylation levels in whole blood of 18-year-old females showed considerable association with the risk of asthma [13]. SNPs of Interleukin-1 receptor–like 1 (IL1RL1), a gene that has been found associated with asthma in GWAS, contributed to the regulation of IL1RL1 methylation in whole blood of asthmatic subjects at age 4. However, there was no considerable link between serum IL1RL1-a protein levels and methylation degree or asthma pathogenesis [127]. Likewise, the study by Larouche et al. [42] supports these results, as they also found no association between asthma and epigenetic regulation of IL1RL1.

The association of the SNPs of genes other than Th cells is also investigated and can be effective in the asthma pathogenesis process. Mukherjee et al. [128] by analyzing a followed-up birth cohort of subjects indicated that SNP-DNA methylation cooperation in modifying the leptin (LEP) gene affects the lung function and can increase the risk of asthma in peripheral blood of 18-year-old subjects. In a clinical study, in response to steroid treatment, the methylation of several groups of CpG sites on the OTX2 gene was in concert with SNPs in nasal epithelial cells of asthmatic children, and this methylation differentiation whether dependent or independent from SNPs could distinguish good responders and poor responders to treatment [129]. Nevertheless, in childhood asthma, although the contribution of both CpG and SNPs in the ORMDL3 expression in whole blood was observed, SNP-CpG interaction did not cooperate in this regulation [130]. On the other hand, another study revealed that the SNP at the enhancer locus of ORMDL3 affected its CpG methylation in isolated endobronchial airway epithelial cells and, therefore, altered the gene expression in asthmatic subjects [131]. By utilizing a novel statistical method, which is canonical analysis of set interactions (CASI) on a genome-wide scale, Kogan et al. [132] have assessed statistical SNP-CpG interactions. Their analyses in DNA extracted from whole blood led to identifying three genes whose CpG sites methylation was correlated to a DNA variation in SNPs, which may be the cause of asthma pathogenesis.

To sum up, these studies emphasize the more effective function of considering both genetic and epigenetic factors rather than just one. In this section, most of the studies were conducted on DNA extracted from whole blood and PBMC and very few on epithelial cells. Unlike nasal samples, there is a mixture of epigenetic patterns in whole blood and PBMC due to the presence of a variety of cells, so they cannot be considered an ideal tissue type. Importantly, it is revealed that the link between CpG methylation and SNPs depends on the time points, so it highlighted the key role of age in this area of study, which is poorly investigated. Table 6 presents a summary of experiments in which the interaction between SNPs and DNA methylation is assessed.

Table 6 Summary of the research works about SNP-CpG methylation interaction on specific genes in asthma

Epigenetic differentiation studies

Further implications of identifying epigenetic differentiation in asthma are to discern types and stages of asthma, advantages, and disadvantages of treatment and also to discover a suitable tissue type for these studies. The methylation profile of asthma remission, despite the absence of asthma symptoms, was distinguishable from healthy controls by the difference in 1163 CpG sites and 328 regions in bronchial biopsies. Additionally, remission and persistence in asthma varied by even a smaller difference, 42 regions [133]. Among the numbers of loci globally differentiating allergic subjects, aspirin-intolerant asthmatic subjects, and control group, the CYP26A1 gene was distinctly methylated in each of them. Hypermethylation of the CYP26A1 promoter and decrease in its expression was observed in the PBMC isolated CD19 + B lymphocytes of the cohort with allergic asthma utilizing HELP assay [134]. Gunawardhana et al. [135] identified PBMC CpG loci differentially methylated in three inflammatory phenotypes of asthma assessed in CD14 + purified monocytes, including eosinophilic asthma, paucigranulocytic asthma, and neutrophilic asthma. Their results also suggested that a distinct type of asthma may result from an aberrant cytokine expression that may be the result of varied methylation patterns. Studying discordancy in monozygotic twins about ex vivo data, Runyon et al. [136] inferred that the varied DNA methylation patterns of asthmatic adults were associated with the dysfunction of effector T-cells (Teff) and Tregs isolated from whole peripheral blood and BALF. This study also demonstrated that increased methylation of FOXP3 and IFN-γ led to their lower expression in Tregs and Teffs, respectively, in discordant asthmatic twin pairs.

Several investigations have been done signifying the correlation between asthma severity and methylation levels of asthma-related genes. In 2011, Isidoro-Garcı´a et al. [137] found different levels of methylation at the prostaglandin D2 receptor gene (PTGDR) promoter in various asthmatic patients. Their results demonstrated that the hypomethylation of the PTGDR gene provoked an increase in its expression in PBMC derived CD19 + B lymphocytes. This led to a hypothesis that the different methylation level was related to the severity of allergic asthma, thus making it a future therapeutic and diagnostic target. Nevertheless, although ADAM 33 is identified as a factor underlying asthma exacerbation [138], there was not a considerable difference in peripheral blood leukocytes CpG methylation of the exon 9 of this gene between asthmatic adults and controls [139]. In a study by Cosio et al. [140], both mild and severe asthma patients witnessed declined HDAC and augmented HAT activities in PBMC derived alveolar macrophages. The results show that glucocorticoid treatment in patients with moderate asthma results in HDAC1 increase and restrain TNF-α and HAT and, therefore, suppresses Nf-kB and through that restrains IL-8. Only mild asthmatic patients responded to prednisolone treatment with increased HDAC1 and decreased IL-8 [140]. In another study using nasal epithelial cells, effective or feeble response to corticosteroid treatment was reflected in DNA methylation of the Vanin-1 gene promoter as well as the mRNA expression in childhood asthma (Fig. 5) [141]. Furthermore, genome-wide studies identified several CpG regions on the OTX2 gene whose DNA methylation decrement in nasal epithelial cells was considered a response to steroid treatment in well-responded children with asthma [129]. Moreover, severe eosinophilic asthma with glucocorticoid resistance showed a lower level of HDAC2 and total HDAC than that of moderate patients [37]. These studies suggest that asthma severity depends on the methylation or acetylation degree, but these modifications are highly dependent on the cell type, and as long as characteristic dependent effects, like age and gender, on them are not precluded, these sorts of measurements may be inconclusive and biased.

Fig. 5

Change in DNA methylation and mRNA expression of Vanin-1 (VNN1) in response to corticosteroid treatment. a The differentiation of CpG methylation ratio in VNN1 promoter region between good responders and bad responders to corticosteroid treatment. b the association between the VNN1 CpG methylation and the mRNA expression [Reprinted with permission from Elsevier] [141]

Reflection of response to the treatments differs in mild and severe asthma as well as in different tissue types. Regarding the deductions of several studies, PBMC is not a well-recommended tissue type to study the epigenetic process of asthma [47, 49, 140, 142] as opposed to airway epithelial cells and nasal epithelial cells [143]. An epigenome-wide association study identified associations between asthmatic phenotype and methylation profile in different CpG sites using peripheral blood leukocytes, indicating that using whole blood instead can bias the results [143]. On the contrary, Xu et al. [144] via a large-scale epigenome-wide meta-analysis have shown that whole blood methylation analysis can be beneficial in finding differentiated CpG methylation correlated to childhood asthma, and since their findings were also partially in line with airway epithelial cells. In their study, 14 CpG regions were identified showing consistent hypomethylation in different time points, while it was not the case for cord blood DNA [144]. Moreover, another epigenome-wide meta-analysis study has also revealed new CpG sites with differentiated methylation in cord blood and whole blood of newborns and children with asthma, respectively, with only the latter being replicable in respiratory epithelium cells and eosinophils [145]. Yang et al. [146] in a study on childhood atopic asthma in 2017, compared their discovered methylation changes in nasal epithelial cells with their findings derived from PBMC in their previous study in 2015. Although the differentiated methylation profiles had few overlaps between PBMC and epithelial cells, findings from the latter were about tenfold greater than the former. Further, through recent bioinformatics analysis, Shi et al. [147] have found 146 differentially methylated genes, including tumor necrosis factor (TNF) and HLA-DBA1, using the data from the study by Yang et al. [146] in which 186 differentially methylated genes were discovered in nasal epithelial cells in children with atopic asthmatic. In both of these studies, methylation alternations in genes were concordant with their expression. This also shows that bioinformatics is a viable approach to analyze methylation modifications and their consequent impact on expression in asthma and epithelial cells.

In brief, a positive point about these studies is that almost all of them were cell-specific, which increases the reliability of their outcomes. There was no in vivo experiment on this aspect, and all of them were human research. In both histone modification and DNA methylation studies, whole blood or PBMC did not perform as an ideal type of tissue, although PBMC was used in most of the cell-specific studies. Buccal cells have also shown potential for measuring epigenetic modifications and it is more advantageous in sampling children as it is less invasive than others. However, Talens et al. [148] suggested that there is a correlation between methylation in blood and buccal cells, so it cannot be fully determined which one is more suitable. As sampling bronchial epithelium is not readily possible, nasal epithelial cells seem to be a suitable surrogate for being safer and easier to obtain and can also be a reflection of the changes in bronchial airway cells [149, 150]. Table 7 presents a list of studies that are reviewed in this chapter.

Table 7 Summary of epigenetic differentiation studies in asthma

Concluding remarks and suggestions for future works

This article has explained the modulation of asthma predisposition, pathogenesis, and exacerbation through epigenetic modifications. DNA methylation is the most studied area in asthma, playing a key role in mediating environmental effects and interactions with genetic elements. Although histone modifications contribute to the oxidative stress process caused by environmental factors, only a small number of studies are allocated to the role of these modifications caused by various external stimuli. What is more, epigenetic changes, including both asthma inhibitors and developers, can be passed on to future generations. Since these changes are reversible, improving our knowledge in this area can lead to discovering efficient therapeutic targets and drugs as well as diagnostic tools for different types of asthma. Additionally, due to the existing cross talk between histone modifications and other epigenetic regulations [151], exploring the combined effects of them in regulatory genes in asthma may provide valuable information. Several studies mentioned the potential effect of owning pets as early-life exposures on methylation patterns and in the development of asthma, but it is not yet investigated exclusively. Notably, since the majority of studies were carried out after the disease occurrence, it cannot yet be determined whether epigenetic effects caused inflammation in asthma or the opposite, but longitudinal studies certainly pave the way for elucidating this matter. Although followed-up birth cohort studies were able to estimate the odds of asthma before the disease occurrence based on methylation differentiation, these studies lacked sample population size or some of them failed to replicate their results; therefore, more studies need to be done in this area. Several factors influenced most of the studies. The studies that assessed both SNPs and DNA methylation found the link between these two vital when measuring methylation differentiations. Age was also another pivotal factor that affected the results of almost all of the studies on epigenetics in asthma. The type of tissue used for the study highly influences the results because not only epigenetic regulations are cell-specific but also tissues like nasal epithelial cells can reflect the changes in the epithelium better than tissues like whole blood or PBMC. Each future study should consider more of these factors simultaneously when analyzing epigenetic modifications involved in asthma.

Availability of data and materials

Not applicable.





The beta-2 adrenergic receptor


Body mass index


Bronchial alveolar fluid




The fractional concentration of NO


Forkhead box P3


Genome-wide analysis studies


Histone deacetylases


Histone acetyltransferase






Induced nitric oxide synthase


Leptin gene


Nitric oxide


Nuclear factor-κB


Prostaglandin D2 receptor


Peripheral blood mononuclear cells


Single-nucleotide polymorphisms


Suppressor of cytokine signaling-3


Tumor necrosis factor


T helper cells


Effector T-cells


Regulatory T-cells


  1. 1.

    Ho SM. Environmental epigenetics of asthma: an update. J Allergy Clin Immunol. 2010;126(3):453–65.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Patel TR. Sur SJCoia, immunology c. IgE and eosinophils as therapeutic targets in asthma. Curr Opin Allergy Clin Immunol. 2017;17(1):42–9.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Jabeen U, Zeeshan F, Bano I, Bari A, Rathore AWJJOTPMA. Adherence to asthma treatment and their association with asthma control in children. J Pak Med Assoc. 2018;68(5):725–8.

    PubMed  Google Scholar 

  4. 4.

    Yang IV, Schwartz DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med. 2011;183(10):1295–301.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Moore LD, Le T, Fan GJN. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science. 2010;330(6004):612–6.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Barnes PJ. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(8):693–6.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Keramatinia A, Ahadi A, Akbari ME, Mohseny M, Mosavi Jarahi A, Bahadori-Monfared A, et al. The roles of DNA epigenetics and clinical significance in Chronic Myeloid Leukemia: a review. Cell Mol Biol (Noisy-le-Grand, France). 2018;64(9):58–63.

    Article  Google Scholar 

  9. 9.

    Song J, Cano-Rodriquez D, Winkle M, Gjaltema RAF, Goubert D, Jurkowski TP, et al. Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2017;312(3):L334–47.

    PubMed  Article  Google Scholar 

  10. 10.

    Brook PO, Perry MM, Adcock IM, Durham AL. Epigenome-modifying tools in asthma. Epigenomics. 2015;7(6):1017–32.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Shaikhpoor M, Ahangari G, Sadeghizadeh M, Khosravi A, Deilami GD. Significant changes in D2-like dopamine gene receptors expression associated with non-small-cell lung cancer: could it be of potential use in the design of future therapeutic strategies? Curr Cancer Therapy Rev. 2012;8(4):304–10.

    CAS  Google Scholar 

  12. 12.

    Miller RL, Lawrence J. Understanding root causes of asthma. Perinatal environmental exposures and epigenetic regulation. Ann Am Thorac Soc. 2018;15(Supplement_2):S103–8.

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Soto-Ramírez N, Arshad SH, Holloway JW, Zhang H, Schauberger E, Ewart S, et al. The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years. Clin Epigenet. 2013;5(1):1.

    Article  CAS  Google Scholar 

  14. 14.

    Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther. 2018;186:98–113.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Paul WE, Zhu J. How are TH 2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10(4):225–35.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Medoff BD, Thomas SY, Luster AD. T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol. 2008;26:205–32.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mut Res/Fundam Mol Mech Mutagen. 2010;690(1–2):24–39.

    CAS  Article  Google Scholar 

  18. 18.

    Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just TH2 cells. Nat Rev Immunol. 2010;10(12):838–48.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy. 2011;66(8):989–98.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Kharitonov S, Yates D, Robbins R, Barnes P, Logan-Sinclair R, Shinebourne EJTL. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343(8890):133–5.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Ghosh S, Erzurum SC. Modulation of asthma pathogenesis by nitric oxide pathways and therapeutic opportunities. Drug Discov Today Dis Mech. 2012;9(3–4):e89–94.

    PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Roos AB, Mori M, Gronneberg R, Osterlund C, Claesson HE, Wahlstrom J, et al. Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS. PLoS ONE. 2014;9(2):e90018.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  23. 23.

    Breton CV, Byun HM, Wang X, Salam MT, Siegmund K, Gilliland FD. DNA methylation in the arginase-nitric oxide synthase pathway is associated with exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med. 2011;184(2):191–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Baccarelli A, Rusconi F, Bollati V, Catelan D, Accetta G, Hou L, et al. Nasal cell DNA methylation, inflammation, lung function and wheezing in children with asthma. Epigenomics. 2012;4(1):91–100.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC, Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol. 2005;175(6):3846–61.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheumatism. 2008;58(9):2686–93.

    PubMed  Article  Google Scholar 

  27. 27.

    Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63(5):321–9.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Rostami N, Mazloumi Z, Aghamaleki F, Rad S, Movafagh A, Sheikhpour M. Immunotherapy in breast cancer. Clin Cancer Investig J. 2019;8(4):139–43.

    CAS  Google Scholar 

  29. 29.

    Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Investig. 2008;118(11):3546–56.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production. J Exp Med. 1999;190(9):1309–18.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-γ. Mediat Inflamm. 2001;10(2):51–9.

    CAS  Article  Google Scholar 

  32. 32.

    Brand S, Kesper DA, Teich R, Kilic-Niebergall E, Pinkenburg O, Bothur E, et al. DNA methylation of TH1/TH2 cytokine genes affects sensitization and progress of experimental asthma. J Allergy Clin Immunol. 2012;129(6):1602-10.e6.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Kwon NH, Kim JS, Lee JY, Oh MJ, Choi DC. DNA methylation and the expression of IL-4 and IFN-γ promoter genes in patients with bronchial asthma. J Clin Immunol. 2008;28(2):139–46.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Verma M, Chattopadhyay BD, Paul BN. Epigenetic regulation of DNMT1 gene in mouse model of asthma disease. Mol Biol Rep. 2013;40(3):2357–68.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Wawrzyniak P, Wawrzyniak M, Wanke K, Sokolowska M, Bendelja K, Rückert B, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139(1):93–103.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Forno E, Wang T, Qi C, Yan Q, Xu CJ, Boutaoui N, et al. DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study. Lancet Respir Med. 2019;7(4):336–46.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Li CY, Peng J, Ren LP, Gan LX, Lu XJ, Liu Q, et al. Roles of histone hypoacetylation in LAT expression on T cells and Th2 polarization in allergic asthma. J Transl Med. 2013;11:26.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Seumois G, Chavez L, Gerasimova A, Lienhard M, Omran N, Kalinke L, et al. Epigenomic analysis of primary human T cells reveals enhancers associated with T H 2 memory cell differentiation and asthma susceptibility. Nat Immunol. 2014;15(8):777.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Kubo M, Inoue H. Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia. Curr Allergy Asthma Rep. 2006;6(1):32–9.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Mishra V, Sharma R, Chattopadhyay B, Paul BN. Epigenetic modification of suppressor of cytokine signaling-3 in asthmatic mouse lung: Role of interleukin-6. J Appl Pharm Sci. 2011;1(5):81–9.

    Google Scholar 

  41. 41.

    Gagné-Ouellet V, Guay SP, Boucher-Lafleur AM, Bouchard L, Laprise C. DNA methylation signature of interleukin 1 receptor type II in asthma. Clin Epigenet. 2015;7(1):1–4.

    Article  CAS  Google Scholar 

  42. 42.

    Larouche M, Gagne-Ouellet V, Boucher-Lafleur AM, Larose MC, Plante S, Madore AM, et al. Methylation profiles of IL33 and CCL26 in bronchial epithelial cells are associated with asthma. Epigenomics. 2018;10(12):1555–68.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Liu C, Zhang X, Xiang Y, Qu X, Liu H, Liu C, et al. Role of epithelial chemokines in the pathogenesis of airway inflammation in asthma. Mol Med Rep. 2018;17(5):6935–41.

    CAS  PubMed  Google Scholar 

  44. 44.

    Clifford RL, Patel JK, John AE, Tatler AL, Mazengarb L, Brightling CE, et al. CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET. Am J Physiol Lung Cell Mol Physiol. 2015;308(9):L962–72.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  45. 45.

    John AE, Zhu YM, Brightling CE, Pang L, Knox AJ. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-κB p65, C/EBPβ, and RNA polymerase II binding to the CXCL8 promoter. J Immunol. 2009;183(7):4682–92.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Cheng Q, Shang Y, Huang W, Zhang Q, Li X, Zhou Q. p300 mediates the histone acetylation of ORMDL3 to affect airway inflammation and remodeling in asthma. Int Immunopharmacol. 2019;76:105885.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Li LB, Leung DY, Martin RJ, Goleva E. Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma. Am J Respir Crit Care Med. 2010;182(7):877–83.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Butler CA, McQuaid S, Taggart CC, Weldon S, Carter R, Skibinski G, et al. Glucocorticoid receptor beta and histone deacetylase 1 and 2 expression in the airways of severe asthma. Thorax. 2012;67(5):392–8.

    PubMed  Article  Google Scholar 

  49. 49.

    Gunawardhana LP, Gibson PG, Simpson JL, Powell H, Baines KJ. Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma. Clin Exp Allergy. 2014;44(1):47–57.

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Wu H, Sun YE. Epigenetic regulation of stem cell differentiation. Pediatr Res. 2006;59(4):21–5.

    Article  Google Scholar 

  51. 51.

    Stadhouders R, Li BWS, de Bruijn MJW, Gomez A, Rao TN, Fehling HJ, et al. Epigenome analysis links gene regulatory elements in group 2 innate lymphocytes to asthma susceptibility. J Allergy Clin Immunol. 2018;142(6):1793–807.

    CAS  PubMed  Article  Google Scholar 

  52. 52.

    Naumova AK, Al Tuwaijri A, Morin A, Vaillancout VT, Madore AM, Berlivet S, et al. Sex- and age-dependent DNA methylation at the 17q12-q21 locus associated with childhood asthma. Hum Genet. 2013;132(7):811–22.

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Reinius LE, Gref A, Sääf A, Acevedo N, Joerink M, Kupczyk M, et al. DNA methylation in the Neuropeptide S Receptor 1 (NPSR1) promoter in relation to asthma and environmental factors. PLoS ONE. 2013;8(1):e53877.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Al Tuwaijri A, Gagne-Ouellet V, Madore AM, Laprise C, Naumova AK. Local genotype influences DNA methylation at two asthma-associated regions, 5q31 and 17q21, in a founder effect population. J Med Genet. 2016;53(4):232–41.

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Gao L, Millstein J, Siegmund KD, Dubeau L, Maguire R, Gilliland FD, et al. Epigenetic regulation of AXL and risk of childhood asthma symptoms. Clin Epigenet. 2017;9(1):1–13.

    Article  CAS  Google Scholar 

  56. 56.

    Lovinsky-Desir S, Ridder R, Torrone D, Maher C, Narula S, Scheuerman M, et al. DNA methylation of the allergy regulatory gene interferon gamma varies by age, sex, and tissue type in asthmatics. Clin Epigenet. 2014;6(1):9.

    Article  CAS  Google Scholar 

  57. 57.

    Levine ME, Hosgood HD, Chen B, Absher D, Assimes T, Horvath S. DNA methylation age of blood predicts future onset of lung cancer in the women’s health initiative. Aging (Albany NY). 2015;7(9):690.

    CAS  Article  Google Scholar 

  58. 58.

    Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA methylation clocks in aging: categories, causes, and consequences. Mol Cell. 2018;71(6):882–95.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. 59.

    Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):3156.

    Article  Google Scholar 

  60. 60.

    Peng C, Cardenas A, Rifas-Shiman SL, Hivert MF, Gold DR, Platts-Mills TA, et al. Epigenetic age acceleration is associated with allergy and asthma in children in Project Viva. J Allergy Clin Immunol. 2019;143(6):2263-70.e14.

    PubMed  PubMed Central  Article  Google Scholar 

  61. 61.

    Curtin JA, Simpson A, Belgrave D, Semic-Jusufagic A, Custovic A, Martinez FD. Methylation of IL-2 promoter at birth alters the risk of asthma exacerbations during childhood. Clin Exp Allergy. 2013;43(3):304–11.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Zhang H, Tong X, Holloway JW, Rezwan FI, Lockett GA, Patil V, et al. The interplay of DNA methylation over time with Th2 pathway genetic variants on asthma risk and temporal asthma transition. Clin Epigenet. 2014;6(1):1–11.

    Article  CAS  Google Scholar 

  63. 63.

    Janjanam VD, Mukherjee N, Lockett GA, Rezwan FI, Kurukulaaratchy R, Mitchell F, et al. Tetanus vaccination is associated with differential DNA-methylation: reduces the risk of asthma in adolescence. Vaccine. 2016;34(51):6493–501.

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Guthikonda K, Zhang H, Nolan VG, Soto-Ramírez N, Ziyab AH, Ewart S, et al. Oral contraceptives modify the effect of GATA3 polymorphisms on the risk of asthma at the age of 18 years via DNA methylation. Clin Epigenet. 2014;6(1):1–12.

    Article  CAS  Google Scholar 

  65. 65.

    Sood A, Petersen H, Blanchette CM, Meek P, Picchi MA, Belinsky SA, et al. Methylated genes in sputum among older smokers with asthma. Chest. 2012;142(2):425–31.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  66. 66.

    Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661–6.

    PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Fenger R, Gonzalez-Quintela A, Vidal C, Gude F, Husemoen L, Aadahl M, et al. Exploring the obesity-asthma link: do all types of adiposity increase the risk of asthma? Clin Exp Allergy. 2012;42(8):1237–45.

    CAS  PubMed  Article  Google Scholar 

  68. 68.

    Rastogi D, Suzuki M, Greally JM. Differential epigenome-wide DNA methylation patterns in childhood obesity-associated asthma. Sci Rep. 2013;3:2164.

    PubMed  PubMed Central  Article  Google Scholar 

  69. 69.

    Jeong A, Imboden M, Ghantous A, Novoloaca A, Carsin AE, Kogevinas M, et al. DNA methylation in inflammatory pathways modifies the association between BMI and adult-onset non-atopic Asthma. Int J Environ Res Public Health. 2019;16(4):600.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  70. 70.

    Wu Y, Zhao Y, Xu T, You L, Zhang H, Liu F. Alzheimer’s disease affects severity of asthma through methylation control of Foxp3 promoter. J Alzheimer’s Dis: JAD. 2019;70(1):121–9.

    CAS  Article  Google Scholar 

  71. 71.

    Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of In utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61–73.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Liu X, Agerbo E, Schlunssen V, Wright RJ, Li J, Munk-Olsen T. Maternal asthma severity and control during pregnancy and risk of offspring asthma. J Allergy Clin Immunol. 2018;141(3):886-92.e3.

    PubMed  Article  Google Scholar 

  73. 73.

    Singh SP, Chand HS, Langley RJ, Mishra N, Barrett T, Rudolph K, et al. Gestational exposure to sidestream (Secondhand) cigarette smoke promotes transgenerational epigenetic transmission of exacerbated allergic asthma and bronchopulmonary dysplasia. J Immunol. 2017;198(10):3815–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  74. 74.

    Zacharasiewicz A. Maternal smoking in pregnancy and its influence on childhood asthma. ERJ Open Res. 2016;2(3):00042–2016.

    PubMed  PubMed Central  Article  Google Scholar 

  75. 75.

    Christensen S, Jaffar Z, Cole E, Porter V, Ferrini M, Postma B, et al. Prenatal environmental tobacco smoke exposure increases allergic asthma risk with methylation changes in mice. Environ Mol Mutagen. 2017;58(6):423–33.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  76. 76.

    Gao L, Liu X, Millstein J, Siegmund KD, Dubeau L, Maguire RL, et al. Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypes. Clin Epigenet. 2018;10(1):98.

    Article  CAS  Google Scholar 

  77. 77.

    Neophytou AM, Oh SS, Hu D, Huntsman S, Eng C, Rodriguez-Santana JR, et al. In utero tobacco smoke exposure, DNA methylation, and asthma in Latino children. Environ Epidemiol. 2019;3(3):e048.

    PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    Wu CC, Hsu TY, Chang JC, Ou CY, Kuo HC, Liu CA, et al. Paternal tobacco smoke correlated to offspring asthma and prenatal epigenetic programming. Front Genet. 2019;10(MAY):471.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  79. 79.

    Sarnowski C, Laprise C, Malerba G, Moffatt MF, Dizier MH, Morin A, et al. DNA methylation within melatonin receptor 1A (MTNR1A) mediates paternally transmitted genetic variant effect on asthma plus rhinitis. J Allergy Clin Immunol. 2016;138(3):748–53.

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Perera F, Tang WY, Herbstman J, Tang D, Levin L, Miller R, et al. Relation of DNA methylation of 5’-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS ONE. 2009;4(2):e4488.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  81. 81.

    Jung KH, Torrone D, Lovinsky-Desir S, Perzanowski M, Bautista J, Jezioro JR, et al. Short-term exposure to PM2.5 and vanadium and changes in asthma gene DNA methylation and lung function decrements among urban children. Respir Res. 2017;18(1):1–11.

    Article  CAS  Google Scholar 

  82. 82.

    Prunicki M, Stell L, Dinakarpandian D, de Planell-Saguer M, Lucas RW, Hammond SK, et al. Exposure to NO2, CO, and PM 2.5 is linked to regional DNA methylation differences in asthma. Clin Epigenet. 2018;10:2.

    Article  CAS  Google Scholar 

  83. 83.

    Zhou J, Geng F, Xu J, Peng L, Ye X, Yang D, et al. PM2.5 exposure and cold stress exacerbates asthma in mice by increasing histone acetylation in IL-4 gene promoter in CD4(+) T cells. Toxicol Lett. 2019;316:147–53.

    CAS  PubMed  Article  Google Scholar 

  84. 84.

    Sofer T, Baccarelli A, Cantone L, Coull B, Maity A, Lin X, et al. Exposure to airborne particulate matter is associated with methylation pattern in the asthma pathway. Epigenomics. 2013;5(2):147–54.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  85. 85.

    Jung KH, Lovinsky-Desir S, Yan B, Torrone D, Lawrence J, Jezioro JR, et al. Effect of personal exposure to black carbon on changes in allergic asthma gene methylation measured 5 days later in urban children: importance of allergic sensitization. Clin Epigenet. 2017;9:61.

    Article  CAS  Google Scholar 

  86. 86.

    Zhang X, Myers JMB, Burleson J, Ulm A, Bryan KS, Chen X, et al. Nasal DNA methylation is associated with childhood asthma. Epigenomics. 2018;10(5):629–41.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  87. 87.

    Somineni HK, Zhang X, Biagini Myers JM, Kovacic MB, Ulm A, Jurcak N, et al. Ten-eleven translocation 1 (TET1) methylation is associated with childhood asthma and traffic-related air pollution. J Allergy Clin Immunol. 2016;137(3):797-805.e5.

    CAS  PubMed  Article  Google Scholar 

  88. 88.

    Kuo CH, Hsieh CC, Kuo HF, Huang MY, Yang SN, Chen LC, et al. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation. Allergy. 2013;68(7):870–9.

    CAS  PubMed  Article  Google Scholar 

  89. 89.

    Wang IJ, Karmaus WJJ, Chen SL, Holloway JW, Ewart S. Effects of phthalate exposure on asthma may be mediated through alterations in DNA methylation. Clin Epigenet. 2015;7(1):1–9.

    Article  CAS  Google Scholar 

  90. 90.

    Yang CF, Karmaus WJJ, Yang CC, Chen ML, Wang IJ. Bisphenol a exposure, DNA methylation, and asthma in children. Int J Environ Res Public Health. 2020;17(1):298.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  91. 91.

    Yang IV, Pedersen BS, Liu A, O’Connor GT, Teach SJ, Kattan M, et al. DNA methylation and childhood asthma in the inner city. J Allergy Clin Immunol. 2015;136(1):69–80.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  92. 92.

    Gaffin JM, Raby BA, Petty CR, Hoffman EB, Baccarelli AA, Gold DR, et al. β-2 Adrenergic receptor gene methylation is associated with decreased asthma severity in inner-city schoolchildren: asthma and rhinitis. Clin Exp Allergy. 2014;44(5):681–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  93. 93.

    Fu A, Leaderer BP, Gent JF, Leaderer D, Zhu Y. An environmental epigenetic study of ADRB2 5′-UTR methylation and childhood asthma severity. Clin Exp Allergy. 2012;42(11):1575–81.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  94. 94.

    Nafea OE, El-Korashi LA, Gehad MH, Yousif YM, Zake LG. Association between blood aluminum and beta-2 receptor gene methylation with childhood asthma control. Hum Exp Toxicol. 2020;39:1301–9.

    CAS  PubMed  Article  Google Scholar 

  95. 95.

    Chan MA, Ciaccio CE, Gigliotti NM, Rezaiekhaligh M, Siedlik JA, Kennedy K, et al. DNA methylation levels associated with race and childhood asthma severity. J Asthma. 2017;54(8):825–32.

    CAS  PubMed  Article  Google Scholar 

  96. 96.

    Qi C, Jiang Y, Yang IV, Forno E, Wang T, Vonk JM, et al. Nasal DNA methylation profiling of asthma and rhinitis. J Allergy Clin Immunol. 2020;145:1655–63.

    CAS  PubMed  Article  Google Scholar 

  97. 97.

    Chen X, Lin H, Yang D, Xu W, Liu G, Liu X, et al. Early-life undernutrition reprograms CD4+ T-cell glycolysis and epigenetics to facilitate asthma. J Allergy Clin Immunol. 2019;143(6):2038-51.e12.

    CAS  PubMed  Article  Google Scholar 

  98. 98.

    Montrose L, Ward TJ, Semmens EO, Cho YH, Brown B, Noonan CW. Dietary intake is associated with respiratory health outcomes and DNA methylation in children with asthma. Allergy Asthma Clin Immunol. 2017;13(1):1–12.

    Article  CAS  Google Scholar 

  99. 99.

    Torrone DZ, Kuriakose JS, Moors K, Jiang H, Niedzwiecki M, Perera F, et al. Reproducibility and intraindividual variation over days in buccal cell DNA methylation of two asthma genes, interferon γ (IFNγ) and inducible nitric oxide synthase (iNOS). Clin Epigenet. 2012;4(1):3.

    CAS  Article  Google Scholar 

  100. 100.

    Pech M, Weckmann M, König IR, Franke A, Heinsen FA, Oliver B, et al. Rhinovirus infections change DNA methylation and mRNA expression in children with asthma. PLoS ONE. 2018;13(11):e0205275.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  101. 101.

    von Mutius E. Allergies, infections and the hygiene hypothesis—the epidemiological evidence. Immunobiology. 2007;212(6):433–9.

    Article  CAS  Google Scholar 

  102. 102.

    Jatzlauk G, Bartel S, Heine H, Schloter M, Krauss-Etschmann SJA. Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota. Allergy. 2017;72(12):1859–67.

    CAS  PubMed  Article  Google Scholar 

  103. 103.

    Zuccotti G, Meneghin F, Aceti A, Barone G, Callegari ML, Di Mauro A, et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70(11):1356–71.

    CAS  PubMed  Article  Google Scholar 

  104. 104.

    Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(1):192–8.

    CAS  PubMed  Article  Google Scholar 

  105. 105.

    Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. The Lancet. 2003;361(9372):1869–71.

    Article  Google Scholar 

  106. 106.

    Ehrenstein V, Mutius V, Kries V. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy. 2000;30(2):187–93.

    Article  Google Scholar 

  107. 107.

    Brand S, Teich R, Dicke T, Harb H, Yildirim AO, Tost J, et al. Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes. J Allergy Clin Immunol. 2011;128(3):618-25.e7.

    CAS  PubMed  Article  Google Scholar 

  108. 108.

    Michel S, Busato F, Genuneit J, Pekkanen J, Dalphin JC, Riedler J, et al. Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy. Allergy Eur J Allergy Clin Immunol. 2013;68(3):355–64.

    CAS  Article  Google Scholar 

  109. 109.

    Kyburz A, Fallegger A, Zhang X, Altobelli A, Artola-Boran M, Borbet T, et al. Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells. J Allergy Clin Immunol. 2019;143(4):1496-512.e11.

    CAS  PubMed  Article  Google Scholar 

  110. 110.

    Wang CM, Chang CB, Chan MWY, Wen ZH, Wu SF. Dust mite allergen-specific immunotherapy increases IL4 DNA methylation and induces Der p-specific T cell tolerance in children with allergic asthma. Cell Mol Immunol. 2018;15(11):963–72.

    CAS  PubMed  Article  Google Scholar 

  111. 111.

    He D, Yang CX, Sahin B, Singh A, Shannon CP, Oliveria J-P, et al. Whole blood vs PBMC: compartmental differences in gene expression profiling exemplified in asthma. Allerg, Asthma Clin Immunol. 2019;15(1):67.

    CAS  Article  Google Scholar 

  112. 112.

    Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8(4):253–62.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  113. 113.

    DeVries A, Wlasiuk G, Miller SJ, Bosco A, Stern DA, Lohman IC, et al. Epigenome-wide analysis links SMAD3 methylation at birth to asthma in children of asthmatic mothers. J Allergy Clin Immunol. 2017;140(2):534–42.

    CAS  PubMed  Article  Google Scholar 

  114. 114.

    Murphy TM, Wong CC, Arseneault L, Burrage J, Macdonald R, Hannon E, et al. Methylomic markers of persistent childhood asthma: a longitudinal study of asthma-discordant monozygotic twins. Clin Epigenet. 2015;7:130.

    Article  CAS  Google Scholar 

  115. 115.

    Yue H, Yan W, Ji X, Gao R, Ma J, Rao Z, et al. Maternal exposure of BALB/c mice to indoor NO2 and allergic asthma syndrome in offspring at adulthood with evaluation of DNA methylation associated Th2 polarization. Environ Health Perspect. 2017;125(9):097011.

    PubMed  PubMed Central  Article  Google Scholar 

  116. 116.

    den Dekker HT, Burrows K, Felix JF, Salas LA, Nedeljkovic I, Yao J, et al. Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course. Eur Respir J. 2019;53(4):1801795.

    Article  CAS  Google Scholar 

  117. 117.

    Everson TM, Zhang H, Lockett GA, Kaushal A, Forthofer M, Ewart SL, et al. Epigenome-wide association study of asthma and wheeze characterizes loci within HK1. Allergy Asthma Clin Immunol. 2019;15:43.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  118. 118.

    Rehan VK, Liu J, Naeem E, Tian J, Sakurai R, Kwong K, et al. Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med. 2012;10(1):129.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  119. 119.

    Gregory DJ, Kobzik L, Yang Z, McGuire CC, Fedulov AV. Transgenerational transmission of asthma risk after exposure to environmental particles during pregnancy. Am J Physiol-Lung Cell Mol Physiol. 2017;313(2):L395–405.

    PubMed  PubMed Central  Article  Google Scholar 

  120. 120.

    Fedulov AV, Kobzik L. Allergy risk is mediated by dendritic cells with congenital epigenetic changes. Am J Respir Cell Mol Biol. 2011;44(3):285–92.

    CAS  PubMed  Article  Google Scholar 

  121. 121.

    Mikhaylova L, Zhang Y, Kobzik L, Fedulov AV. Link between epigenomic alterations and genome-wide aberrant transcriptional response to allergen in dendritic cells conveying maternal asthma risk. PLoS ONE. 2013;8(8):e70387.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  122. 122.

    Gunawardhana LP, Baines KJ, Mattes J, Murphy VE, Simpson JL, Gibson PG. Differential DNA methylation profiles of infants exposed to maternal asthma during pregnancy. Pediatr Pulmonol. 2014;49(9):852–62.

    PubMed  Article  Google Scholar 

  123. 123.

    Hollman AL, Tchounwou PB, Huang HC. The Association between Gene-Environment Interactions and Diseases Involving the Human GST Superfamily with SNP Variants. Int J Environ Res Public Health. 2016;13(4):379.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  124. 124.

    Kim S, Forno E, Yan Q, Jiang Y, Zhang R, Boutaoui N, et al. SNPs identified by GWAS affect asthma risk through DNA methylation and expression of cis-genes in airway epithelium. Eur Respir J. 2019;55(4):1902079.

    Article  CAS  Google Scholar 

  125. 125.

    Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F, Turner BM. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem. 2007;282(7):4408–16.

    CAS  PubMed  Article  Google Scholar 

  126. 126.

    Okitsu CY, Hsieh C-L. DNA methylation dictates histone H3K4 methylation. Mol Cell Biol. 2007;27(7):2746–57.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  127. 127.

    Dijk FN, Xu C, Melen E, Carsin AE, Kumar A, Nolte IM, et al. Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma. Eur Respir J. 2018;51(3):1701377.

    PubMed  Article  CAS  Google Scholar 

  128. 128.

    Mukherjee N, Lockett GA, Merid SK, Melén E, Pershagen G, Holloway JW, et al. DNA methylation and genetic polymorphisms of the Leptin gene interact to influence lung function outcomes and asthma at 18 years of age. Int J Mol Epidemiol Genet. 2016;7(1):1–17.

    CAS  PubMed  PubMed Central  Google Scholar 

  129. 129.

    Zhang X, Biagini Myers JM, Yadagiri VK, Ulm A, Chen X, Weirauch MT, et al. Nasal DNA methylation differentiates corticosteroid treatment response in pediatric asthma: A pilot study. PLoS ONE. 2017;12(10):e0186150.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  130. 130.

    Acevedo N, Reinius LE, Greco D, Gref A, Orsmark-Pietras C, Persson H, et al. Risk of childhood asthma is associated with CpG-site polymorphisms, regional DNA methylation and mRNA levels at the GSDMB/ORMDL3 locus. Hum Mol Genet. 2015;24(3):875–90.

    CAS  PubMed  Article  Google Scholar 

  131. 131.

    Nicodemus-Johnson J, Myers RA, Sakabe NJ, Sobreira DR, Hogarth DK, Naureckas ET, et al. DNA methylation in lung cells is associated with asthma endotypes and genetic risk. JCI Insight. 2016;1(20):e90151.

    PubMed  PubMed Central  Article  Google Scholar 

  132. 132.

    Kogan V, Millstein J, London SJ, Ober C, White SR, Naureckas ET, et al. Genetic-epigenetic interactions in asthma revealed by a genome-wide gene-centric search. Hum Hered. 2019;83(3):130–52.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  133. 133.

    Vermeulen CJ, Xu CJ, Vonk JM, Ten Hacken NHT, Timens W, Heijink IH, et al. Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission. Eur Respir J. 2020;55(2):1901280.

    CAS  PubMed  Article  Google Scholar 

  134. 134.

    Pascual M, Suzuki M, Isidoro-Garcia M, Padrón J, Turner T, Lorente F, et al. Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma. Epigenetics. 2011;6(9):1131–7.

    CAS  PubMed  Article  Google Scholar 

  135. 135.

    Gunawardhana LP, Gibson PG, Simpson JL, Benton MC, Lea RA, Baines KJ. Characteristic DNA methylation profiles in peripheral blood monocytes are associated with inflammatory phenotypes of asthma. Epigenetics. 2014;9(9):1302–16.

    PubMed  PubMed Central  Article  Google Scholar 

  136. 136.

    Runyon RS, Cachola LM, Rajeshuni N, Hunter T, Garcia M, Ahn R, et al. Asthma discordance in twins is linked to epigenetic modifications of T cells. PLoS ONE. 2012;7(11):e48796.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  137. 137.

    Isidoro-García M, Sanz C, García-Solaesa V, Pascual M, Pescador DB, Lorente F, et al. PTGDR gene in asthma: a functional, genetic, and epigenetic study. Allergy Eur J Allergy Clin Immunol. 2011;66(12):1553–62.

    Article  CAS  Google Scholar 

  138. 138.

    Jie Z, Hu Z, Bai C, Jin MJ. ADAM33 gene polymorphisms associate with asthma susceptibility and severity in East China Han population. J Asthma. 2011;48(10):979–85.

    CAS  PubMed  Article  Google Scholar 

  139. 139.

    Yang PJ, Li RN, Huang CC, Wang TH, Ko YC, Huang MS, et al. The methylation patterns of a disintegrin and metalloproteinase 33 gene (ADAM33) in adult asthma. Int Arch Allergy Immunol. 2013;161(1):74–80.

    CAS  PubMed  Article  Google Scholar 

  140. 140.

    Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med. 2004;170(2):141–7.

    PubMed  Article  Google Scholar 

  141. 141.

    Xiao C, Biagini Myers JM, Ji H, Metz K, Martin LJ, Lindsey M, et al. Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response. J Allergy Clin Immunol. 2015;136(4):923-31.e3.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  142. 142.

    Arathimos R, Suderman M, Sharp GC, Burrows K, Granell R, Tilling K, et al. Epigenome-wide association study of asthma and wheeze in childhood and adolescence. Clin Epigenet. 2017;9:112.

    Article  CAS  Google Scholar 

  143. 143.

    Lin PI, Shu H, Mersha TB. Comparing DNA methylation profiles across different tissues associated with the diagnosis of pediatric asthma. Sci Rep. 2020;10(1):151.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  144. 144.

    Xu CJ, Söderhäll C, Bustamante M, Baïz N, Gruzieva O, Gehring U, et al. DNA methylation in childhood asthma: an epigenome-wide meta-analysis. Lancet Respir Med. 2018;6(5):379–88.

    CAS  PubMed  Article  Google Scholar 

  145. 145.

    Reese SE, Xu CJ, den Dekker HT, Lee MK, Sikdar S, Ruiz-Arenas C, et al. Epigenome-wide meta-analysis of DNA methylation and childhood asthma. J Allergy Clin Immunol. 2019;143(6):2062–74.

    CAS  PubMed  Article  Google Scholar 

  146. 146.

    Yang IV, Pedersen BS, Liu AH, O’Connor GT, Pillai D, Kattan M, et al. The nasal methylome and childhood atopic asthma. J Allergy Clin Immunol. 2017;139(5):1478–88.

    CAS  PubMed  Article  Google Scholar 

  147. 147.

    Shi K, Ge MN, Chen XQ. Coordinated DNA methylation and gene expression data for identification of the critical genes associated with childhood atopic asthma. J Comput Biol: J Comput Mol Cell Biol. 2020;27(1):109–20.

    CAS  Article  Google Scholar 

  148. 148.

    Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, Willemsen G, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 2010;24(9):3135–44.

    CAS  PubMed  Article  Google Scholar 

  149. 149.

    Brugha R, Lowe R, Henderson AJ, Holloway JW, Rakyan V, Wozniak E, et al. DNA methylation profiles between airway epithelium and proxy tissues in children. Acta Paediatr. 2017;106(12):2011–6.

    CAS  PubMed  Article  Google Scholar 

  150. 150.

    Poole A, Urbanek C, Eng C, Schageman J, Jacobson S, O’Connor BP, et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol. 2014;133(3):670–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  151. 151.

    Zwinderman MR, Cao F, Dekker FJ. Acetylation and methylation in asthma, COPD, and lung cancer. In: Mai A, editor. Chemical epigenetics. Topics in Medicinal Chemistry. Cham: Springer; 2019.

    Google Scholar 

Download references


Not applicable.

Author information




Mojgan Sheikhpour: Writing; Reviewing and Editing; Supervision; Validation. Mobina Maleki: Data curation, Writing- Original draft preparation. Maryam Ebrahimi Vargoorani: Visualization, Investigation. Vahid Amiri: Investigation; Methodology. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mojgan Sheikhpour.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sheikhpour, M., Maleki, M., Ebrahimi Vargoorani, M. et al. A review of epigenetic changes in asthma: methylation and acetylation. Clin Epigenet 13, 65 (2021).

Download citation


  • DNA methylation
  • Acetylation
  • Epigenetic
  • Lung diseases
  • Asthma
  • Gene expression